[1]高 鹏,林文华,敬 锐,等.红细胞压积变化对急性ST段抬高型心肌梗死患者临床预后的影响[J].医学信息,2019,(03):78-81.[doi:10.3969/j.issn.1006-1959.2019.03.024]
 GAO Peng,LIN Wen-hua,JING Rui,et al.Effect of Hematocrit Changes on Clinical Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction[J].Medical Information,2019,(03):78-81.[doi:10.3969/j.issn.1006-1959.2019.03.024]
点击复制

红细胞压积变化对急性ST段抬高型心肌梗死患者临床预后的影响()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年03期
页码:
78-81
栏目:
论著
出版日期:
2019-02-01

文章信息/Info

Title:
Effect of Hematocrit Changes on Clinical Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction
文章编号:
1006-1959(2019)03-0078-04
作者:
高 鹏林文华敬 锐邸成业
(泰达国际心血管病医院内一科,天津 300457)
Author(s):
GAO PengLIN Wen-huaJING RuiDI Cheng-ye
(Department of Internal Medicine,Subject One,TEDA International Cardiovascular Hospital,Tianjin 300457,China)
关键词:
红细胞压积贫血急性心肌梗死冠状动脉粥样硬化性心脏病
Keywords:
HematocritAnemiaAcute myocardial infarctionCoronary atherosclerotic heart disease
分类号:
R542.22
DOI:
10.3969/j.issn.1006-1959.2019.03.024
文献标志码:
A
摘要:
目的 探讨红细胞压积的变化对急性ST段抬高型心肌梗死(STEMI)接受急诊经皮冠状动脉支架植入术患者的临床预后的影响。方法 连续性纳入我院心肌梗死绿色通道收治行急诊支架植入患者603例,根据住院期间红细胞压积的变化分为A组(红细胞压积降低组,255例)和B组(红细胞压积升高组,348例)。收集两组患者资本资料、手术相关信息、化验室资料、住院期间临床事件、1个月内临床事件以及1年内临床事件并予以统计分析。结果 A组年龄大于B组[(60.33±11.06)岁 vs(58.44±10.88)岁,P<0.05],B组脑血管病史发生率高与A组(13.50% vs 8.24%,P<0.05),A组梗死相关动脉中血栓病变发发生率高于B组(97.25% vs 88.51%,P<0.05)。支架植入后最终TIMI血流:3级血流A组较B组高(85.88% vs 79.02%,P<0.05)。A组较B组住院期间心源性死亡发生率低(0 vs 2.01%,P<0.05);出院1年内LVEF低于B组[(55.53±6.42)% vs (57.19±6.82)%,P<0.05];出院1年室壁运动异常发生率高于B组(92.88% vs 87.69%,P<0.05)。结论 住院期间红细胞压积升高增加STEMI患者在院期间心源性死亡的发生,红细胞压积降低预示着心功能的下降及室壁运动功能受损。
Abstract:
Objective To investigate the effect of changes in hematocrit on the clinical outcome of patients undergoing emergency percutaneous coronary stenting in patients with acute ST-segment elevation myocardial infarction (STEMI). Methods 603 patients with emergency stent implantation were enrolled in the green channel of myocardial infarction in our hospital. According to the changes of hematocrit during hospitalization, they were divided into group A (red blood cell reduction group, 255 cases) and group B (increased hematocrit, 348 cases). Capital data, surgical related information, laboratory data, clinical events during hospitalization, clinical events within 1 month, and clinical events within 1 year were collected and statistically analyzed. Results The age of group A was higher than that of group B [(60.33±11.06) years old vs (58.44±10.88) years old, P<0.05]. The incidence of cerebrovascular disease in group B was higher than that in group A (13.50% vs 8.24%, P<0.05). The incidence of thrombosis in infarct-related arteries in group A was higher than that in group B (97.25% vs 88.51%, P<0.05). Final TIMI blood flow after stent implantation: Grade 3 blood flow was higher in group A than in group B (85.88% vs 79.02%, P<0.05). The incidence of cardiac death was lower in group A than in group B (0 vs 2.01%, P<0.05); LVEF was lower in group than in group B within 1 year [(55.53±6.42)% vs (57.19±6.82)%, P<0.05]; the incidence of abnormal wall motion at 1 year was higher than that of group B (92.88% vs 87.69%, P<0.05). Conclusion Increased hematocrit during hospitalization increases cardiac death during hospitalization in STEMI patients. Decreased hematocrit indicates a decline in cardiac function and impaired wall motion.

参考文献/References:


[1]Kaiafa G,Kanellos I,Savopoulos C,et al.Is anemia a new cardiovascular risk factor?[J].Int J Cardiol,2015,186(3):117-124.
[2]Chehab O,Qannus AS,Eldirani M,et al.Predictors of in-hospital mortality in patients admitted with acute myocardial infarction in a developing country[J].Cardiol Res,2018,9(5):293-299.
[3]Milwidsky A,Berliner S.Anemia in cardiovascular disease: a prognostic marker or part of the disease?[J].Harefuah,2014,153(3-4):184-187.
[4]Hayashi T,Joki N,Tanaka Y,et al.Anaemia and early phase cardiovascular events on haemodialysis [J].Nephrology(Carlton),2015,20(4):1-6.
[5]Sawicki KT,Chang HC,Ardehail H.Role of heme in cardiovascular physiology and disease[J].J Am Heart Assoc,2015,4(1):e001138.
[6]Toth A,Sandor B,Marton Z,et al.Comparison of hemorheological change in patients after acute coronary events, intervention and ambulatory rehabilitation[J].Clin Hemorheol Microcirc,2016,64(4):565-574.
[7]AI-Daydamony MM,Farag EM.CRUSADE bleeding score as a predictor of bleeding events in patients with acute coronary syndrome in Zagazig university hospital[J].Indian Heart J,2016,68(5):632-638.
[8]AI-Hijji MA,Gulati R,Lennon RJ,et al.Outcome of percutaneous coronary in patients with anemia presenting with acute coronary syndrome[J].Mayo Clin Proc,2018,93(10):1448-1461.
[9]Ntima G,Bepouka B,Tixier V,et al.Anemia in patients with acute coronary syndrome in the vichy hospital center[J].Ann Cardiol Angeiol,2018,64(3):125-133.
[10]Stucchi M,Cantoni S,Piccinelli E,et al.Anemia and acute coronary syndrome: current perspectives[J].Vasc Health Risk Manag,2018,30(14):109-118.
[11]Yazji K,Abdul F,Elangovan S,et al.Baseline anemia in patients undergoing percutaneous coronary intervention after an acute coronary syndrome-A paradox of high bleeding risk, high ischemic risk, and complex coronary disease[J].J Interv Cardiol,2017,30(5):491-499.
[12]Ohana-Sarna-Cahan L,Atar S.Clinical outcomes of patients with coronary syndrome and moderate or severe chronic anaemia undergoing coronary angiography or intervention[J].Eur Heart J Acute Cardiovasc Care,2018,7(7):646-651.
[13]White HD,Thyqesen K,Alpert JS,et al.Clinical implications of the third universal definition of myocardial infarction[J].Heart,2014,100(5):424-432.
[14]包丽华.不同采血方法进行血常规检测在临床应用中的研究[J].医学信息,2015,28(46):264.
[15]李洪芳,郗爱旗.红细胞及其相关参数与心血管疾病关系的研究进展[J].医学信息,2016,29(1):19-20.
[16]Janssen PW,Bergmeijer TO,Godschalk TC,et al.The effect of correcting verifynow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions[J].J Thromb Haemost,2017,15(4):618-623.
[17]Kwok CS,Tiong D,Pradhan A,et al.Meta-analysis of the prognostic impact of anemia in patients undergoing percutaneous coronary intervention[J].Am J Cardiol,2016,118(4):610-620.
[18]Ruocco G, Verbrugge FH, Nuti R, et al. Hyponatremia in acute heart failure in relation to hematocrit levels: clinical relevance and prognostic implication[J]. Cardiorenal Med,2018,8(4):259-270.
[19]Zhou H,Xu T,Huang Y,et al.The top tertile of hematocrit change during hospitalization is associated with lower risk of mortality in acute heart failure patients[J].BMC Cardiovasc Disord,2017,17(1):235.
[20]Brener SJ,Mehran R,Dangas GD,et al.Relation of baseline hemoglobin levels and adverse events in patients with acute coronary syndromes (from the acute catherization and urgent intervention triage strategy and harmonizing outcomes with revascularization and stents in acute myocardial infarction trials)[J].Am J Cardiol,2017,119(11):1710-1716.
[21]Kosmidou I,Embacher M,McAndrew T,et al.Early ventricular tachycardia or fibrillation in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention and impact on mortality and stent thrombosis (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial)[J].Am J Cardiol,2017,120(10):1755-1760.
[22]Ibanex B,James S,Agewall S,et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)[J].Eur Heart J,2018,39(2):119-177.

相似文献/References:

[1]贾鹏飞,袁 莉,赵利鹏,等.肝移植围术期EPO应用的效果及安全性研究[J].医学信息,2018,(05):74.[doi:10.3969/j.issn.1006-1959.2018.05.024]
 JIA Peng-fei,YUAN Li,ZHAO Li-peng,et al.Study on the Effect and Safety of EPO in Perioperative Period of Liver Transplantation[J].Medical Information,2018,(03):74.[doi:10.3969/j.issn.1006-1959.2018.05.024]
[2]单 静,贺 晶.胎母输血综合征的诊治[J].医学信息,2018,(08):46.[doi:10.3969/j.issn.1006-1959.2018.08.015]
 SHAN Jing,HE Jing.Diagnosis and Treatment of Fetal Maternal Transfusion Syndrome[J].Medical Information,2018,(03):46.[doi:10.3969/j.issn.1006-1959.2018.08.015]
[3]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
 WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Medical Information,2018,(03):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
[4]张运昊.重组人促红细胞生成素治疗胃肠道恶性肿瘤化疗相关性贫血的疗效观察[J].医学信息,2019,(08):151.[doi:10.3969/j.issn.1006-1959.2019.08.046]
 ZHANG Yun-hao.Therapeutic Effect of Recombinant Human Erythropoietin on Chemotherapy-associated Anemia of Gastrointestinal Malignant Tumor[J].Medical Information,2019,(03):151.[doi:10.3969/j.issn.1006-1959.2019.08.046]
[5]何大海.平均红细胞血红蛋白含量对糖化血红蛋白结果的影响研究[J].医学信息,2019,(09):85.[doi:10.3969/j.issn.1006-1959.2019.09.027]
 HE Da-hai.Effect of Mean Red Blood Cell Hemoglobin Content on Glycosylated Hemoglobin[J].Medical Information,2019,(03):85.[doi:10.3969/j.issn.1006-1959.2019.09.027]
[6]黄正辉,陈小兵,刘高伦.血液透析患者贫血与超敏CRP的相关性研究[J].医学信息,2019,(19):112.[doi:10.3969/j.issn.1006-1959.2019.19.035]
 HUANG Zheng-hui,CHEN Xiao-bing,LIU Gao-lun.Correlation Study Between Anemia and Hypersensitive C-reactive Protein in Hemodialysis Patients[J].Medical Information,2019,(03):112.[doi:10.3969/j.issn.1006-1959.2019.19.035]

更新日期/Last Update: 2019-02-25